chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Acute onset severe debilitating 10/10 headache requiring emergency care. The pain was like my head was going to explode and was getting worse. Went to closest ER as fast as my husband could drive me.  Treated with Tylenol, ibuprofen, Reglan, Benadryl, magnesium, and 1mg dilaudid to finally get rid of the headache. CT scan normal. Labs normal. No MRI capabilities. Never had a history of severe headaches; only mild headaches that would improve with one dose of OTC medication.
Developed shingles on the scalp migrating down to the right eye, blisters on the eyelid and surrounding the eye, swelling below the lower eyelid.
Developed 10x11 erythematous, indurated painful area around site of injection in deltoid.  Rx'd with KEFLEX in case of cellulitis.
rash with small bumps on right and left arms on post vaccine day 10, 11, 12 very itch, red, relieved with antihistamines after about 25 minutes .  Today is day 12.
Joints pain; Body aches; No energy; Taste loss; This is a spontaneous report from a non-contactable consumer, the patient. A 28-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3180) via an unspecified route of administration in the left arm on 17Aug2021 at 13:00 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received dextromethorphan hydrobromide/doxylamine succinate/ephedrine sulfate/ethanol/paracetamol (NYQUIL) and guaifenesin (MUCINEX) and experienced drug allergy. On 18Aug2021 at 02:00, the patient experienced joints pain, body aches, no energy and taste loss. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events joints pain, body aches, no energy and taste loss were resolving with sequelae on an unknown date in Aug2021.   No follow-up attempts are possible. No further information is expected.
I have excessive whole body pains. I lack strength. I find sleep difficult. I get leg cramps at night. I lack energy.
Pt called on 10/6/17 to state that since the day of the injection she felt chills, fever, and a red mark on her right arm. Still by 10/6/17 she has a warm circular area on her arm, warm to touch, and hurts to touch, although has gotten better since the injection day 9/28/17. We discussed continuing heat pads and Advil. We discussed patient to follow up with her provider if symptoms do not continue to subside.
Client found out pregnant 2 wks after receiving vaccinations.  Due date of 9/01/09.  Client gave permission on 5/1/09 to report to VARIVAX registry for pregnancy.
Vaccines administered 2/5/2010. About 5 days later fever mild with spikes T 100 at night x 3 days. Mild rash @ 10 days post injections. Client lethargic with poor appetite. 3 weeks after injections. Client taken to ER with fever T 104, lethargic, poor appetite (2/27/10) has rash again over torso - fasting today - 3/2/10. Appetite improving.
h/a 1hr post vax;vomiting rx compazine;T97.6, P76, R18, BP 132/80; 02-97%;
Significant arm pain; This case was reported by a physician via sales rep and described the occurrence of pain in arm in a 17-year-old female patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received Bexsero at an unknown dose. On an unknown date, unknown after receiving Bexsero, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Bexsero.  Additional details were provided as follows: The age at vaccination was not reported. The patient had significant arm pain and was lasted for several days.
chest pain; muscle pain; aches in his arms and legs; anxiety; pain in back of his head; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient. A 64 year-old male patient received bnt162b2 (COMIRNATY), administration date 22Oct2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Comirnaty (DOSE: 2), administration date: 13Apr2021, for COVID-19 immunization, reaction(s): "Chest pain"; Comirnaty (DOSE: 1), for COVID-19 immunization. The following information was reported: CHEST PAIN (non-serious) with onset 23Oct2021, outcome "unknown", described as "chest pain"; MYALGIA (non-serious) with onset 23Oct2021, outcome "unknown", described as "muscle pain"; PAIN IN EXTREMITY (non-serious) with onset 23Oct2021, outcome "recovered" (24Oct2021), described as "aches in his arms and legs"; ANXIETY (non-serious) with onset Oct2021, outcome "unknown", described as "anxiety"; HEADACHE (non-serious) with onset Oct2021, outcome "recovered" (24Oct2021), described as "pain in back of his head". The events "chest pain", "muscle pain", "aches in his arms and legs", "anxiety" and "pain in back of his head" were evaluated at the physician office visit.  Additional information: Patient received his booster dose on 22Oct2021 and noticed the symptoms the following day. Reports having chest pain and asked if this symptom was a side effect of the vaccine and if this symptom was transient or permanent. He also having muscle pain and aches in his arms and legs. His chest pain symptom was more significant this time than the second shot, which he received on 13Apr2021. Chest pain was similar but less pronounced and said he had forgotten all about it. The pain was not related to gas and that he haven't been to the gym or lifting weights. He also said because of it, he was having some anxiety, referring to the chest pain. Caller reports having reached out to his doctor yesterday (25Oct2021) and before contacting Pfizer today. He experienced pain in his arm, leg, and back of his head and chest pain subsided on the 24th except for the chest pain. He ended up going to the hospital on the 27th overnight advised by his physician.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a registered pharmacist concerning a 72 year old male who on approximately 13-NOV-2007 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck) instead of zoster vaccine live (Oka/Merck)(MSD). It was an error and not product confusion. No additional information was available. Unspecified medical attention was sought. There was no product quality complaint. additional information has been requested.
A non-serious spontaneous report of metallic taste in mouth for two weeks has been received from a health professional concerning a 11-year-old female, subsequent to FLUMIST. Neither relevant past medical history nor concomitant medications had been reported for this patient. The patient received FLUMIST in 2009-2010 season. After receiving FLUMIST in 2010, the patient had metallic taste in his mouth for two weeks. The outcome of the event was recovered.
Patient sat in chair. Was asked DOB, allergies, previous flu shot/ rxns, how feeling today - said he was fine today. Asked about his classmates  and why it took so long for them to return to class. He told me of previous flu shot at Pharmacy and "they lied to me". Tried to reassure him I'd be gentle as I could. used alcohol prep pad/ gauze gave shot in the left arm and he started to fall forward with his head.
Systemic: Headache-Severe, Additional Details: had swelling in sinuses and pressure behind her nose.  she also has ringing in her ears
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021 at 9:26 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 31-Mar-2021 at 9:26 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant products were not provided.  It was reported that unknown number of patients were administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of time of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  On 31-Mar-2021, the excursion time on initial supply was 08 am, temperature was 32 and total 199 doses were administered for that day. Vaccine was not frozen prior to administration. Vaccine moved to fridge on 23-Mar-2021 and moved to clinic on 31-Mar-2021. 04 vial was sent to the clinic. BUD date was 22-Apr-2021.   Vials only punctured right before administration.  Treatment medications were not reported.   This case was linked to MOD-2022-566976 (Patient Link).
I took the second shot and remembered I felt the onset of my arm pain and dizziness the next day.  So, this time, I stayed awake until 12 hours after the shot to catch the pain as soon as possible. I didn't take medication after the first shot, but this time, I planned to take Tylenol.  I briefly fell asleep for a few hours and woke up at 3:30 a.m.  Around 3:30 am, I felt a little headache, so I took one extra strength Tylenol.    Around 6:00 pm Tuesday evening, I began to feel a little soreness at the injection site for my 2nd COVID vaccination, which was in my right arm.  For some reason, I also started to feel muscle soreness (similar to the way I felt after the first COVID vaccination), but it was in my left arm (which I did not get the shot for this second vaccination).  I also began feeling pain in my neck.  So I took another extra strength Tylenol.  I also stretched my arms and did pushups, jogged a bit, drank water and massaged my arms.  Then, on Wednesday morning around 8:00 am, my left arm felt the same muscle soreness.  So, I took two extra strength Tylenols.
Patient developed a rash the following day.  The rash covers the sides of her trunk, hips, buttocks, under breasts and neck. The patient reached out to and is seeing her dermatologist later this week.  Patient is using oral and topical Benadryl and topical hydrocortisone 2% cream. The rash is still prevalent as of 7/22/2021.
Blister appeared approximately 1/2 inch above injections site.  Area was red.  Ice pack applied.  Child didn't want to keep it on arm so it was removed.  Instructed mother to watch the area and the child and to seek emergency attention if needed. (ER)
JOINT PAIN; FEVER; This spontaneous report received from a patient concerned a 39 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 206A21A, and expiry: UNKNOWN) dose was not reported, administered on 20-AUG-2021 for prophylactic vaccination.  No concomitant medications were reported. On 20-AUG-2021, the patient experienced joint pain. On 20-AUG-2021, the patient experienced fever. The action taken with covid-19 vaccine was not applicable. The patient had not recovered from fever, and joint pain. This report was non-serious.
Began running a fever overnight.   I had chills all night and didn't sleep well.  I realized why in the morning when I took my temperature and it was 100.4.  I was achy and felt like I had the flu all day.  My fever went as high as 102.2 before I finally took Advil which brought it down to about 100 before it started going up again.  By evening I was fever free and felt better the next day.
Site: Pain at Injection Site-Severe, Systemic: Unable to operate muscles around injection site to the same extent as prior to vaccination.-Severe, Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-
Seizure (status epileptics) less then 24 hours after vaccines requiring intubation, sedation, ventilation for day in the PICU.
5/13 10pm pain at injection site, body aches, chills 5/14  body aches, all over weakness, pain at injection site, irritable, skin painful to touch 5/15 joint popping and pain, all over weakness, pain at injection site, body aches, irritable, skin painful to touch  5/16 all over weakness, no energy, tires easily, joint popping and pain 5/17 all over weakness, tires easily, no energy, joint popping and pain, gets winded quickly
Dizziness; Stabbing pain in both their feet/ It was both her feet, very sharp, and very constant; Very very bad for at least 12 hours; The sore arm extended in the back of her neck, so it became one huge pain in the back to shoulder; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), PAIN IN EXTREMITY (Stabbing pain in both their feet/ It was both her feet, very sharp, and very constant), FEELING ABNORMAL (Very very bad for at least 12 hours) and ARTHRALGIA (The sore arm extended in the back of her neck, so it became one huge pain in the back to shoulder) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Neuropathy (for years).    On 23-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Oct-2021, the patient experienced DIZZINESS (Dizziness), PAIN IN EXTREMITY (Stabbing pain in both their feet/ It was both her feet, very sharp, and very constant), FEELING ABNORMAL (Very very bad for at least 12 hours) and ARTHRALGIA (The sore arm extended in the back of her neck, so it became one huge pain in the back to shoulder). The patient was treated with GABAPENTIN on 23-Oct-2021 for Pain, at a dose of 3 gabapentin at night and GABAPENTIN on 24-Oct-2021 for Pain, at a dose of 2 gabapentin at morning. At the time of the report, DIZZINESS (Dizziness) and PAIN IN EXTREMITY (Stabbing pain in both their feet/ It was both her feet, very sharp, and very constant) had not resolved, FEELING ABNORMAL (Very very bad for at least 12 hours) outcome was unknown and ARTHRALGIA (The sore arm extended in the back of her neck, so it became one huge pain in the back to shoulder) was resolving.            No Concomitant product use was reported.  It was also reported that the patient suffered from neuropathy and these symptoms rarely occurred. The patient took 3 gabapentin on 23-Oct-2021 night and 2 on 24-Oct-2021 morning to alleviate the pain. The sore arm extended in the back of her neck, so it became one huge pain in the back to her shoulder. It's a lot better now 26Oct2021.   Most recent FOLLOW-UP information incorporated above includes: On 26-Oct-2021: Reporter added /Event updated
Vaccine administered was past BUD, no adverse symptoms reported.  Patient is pregnant, due in mid-October 2022.
12x13 large red tender and itchy area centered on the injection site on the left arm. It is also slightly raised and warm to touch.
Patient was given a pediatric dose of Pfizer instead of a 12+ dose of Pfizer. Patient turned 12 years old 1 month before vaccination.
tongue swelling; swelling in throat; This spontaneous case was reported by a consumer and describes the occurrence of SWOLLEN TONGUE (tongue swelling) and PHARYNGEAL SWELLING (swelling in throat) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced SWOLLEN TONGUE (tongue swelling) and PHARYNGEAL SWELLING (swelling in throat). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Swelling of tongue and Throat swelling, at a dose of UNK dosage form. At the time of the report, SWOLLEN TONGUE (tongue swelling) and PHARYNGEAL SWELLING (swelling in throat) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported.
Vaccination at 9:00am. Some discomfort but not real pain in upper arm throughout the day, but became really tired later in the day and went to bed early. Got up to use the bathroom at about 11:30pm.  Swung my legs out of bed to the floor and went to stand up but fell forward to the carpet.  I had no strength in my legs or arms.  I laid on the floor about 10 minutes and could not roll over or sit up or get up to my knees.  My wife came around and helped me get up and back on the bed.  She then helped me down the hall to the bathroom, then back to the bedroom.  She helped me back to the bathroom one other time that night.  I stayed in bed for several hours and was very week and mostly sat all day,  I regained my strength over the next three days to where I could stand and walk, although I was very fatigued.  I am now about 9 days later and feel pretty much normal but get fatigued and my balance is not normal.
As patient left parking lot, started experiencing fever, loss of hearing. Numbness in hands, slurred speech. Pulled over and felt faint. Felt better in about 30 minutes. Symptom have all disappeared.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP) from product quality group.  A 39 year-old male patient received bnt162b2 (BNT162B2), administration date 30Nov2021 (Lot number: FF2589) at the age of 38 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for Covid-19 immunization. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19".  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on the information currently available, lack of efficacy of the suspected vaccine BNT162B2 cannot be completely excluded.
Localized mild erythema and hive-like swelling. No fevers or pain.
This is a spontaneous report from a contactable Pharmacist via Pfizer sales representative. A patient of unspecified age and gender received PREVNAR 13 via an unspecified route of administration at single dose on an unspecified date for immunisation. The patient medical history and concomitant medications were not reported. The patient experienced patient experienced achiness for 1-2 days at the injection site after vaccination on an unspecified date. The outcome of the event was recovered. Information on the batch number has been requested
No adverse event; 113 Bivalent doses administered after the BUD to patients 12 and up; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up) and NO ADVERSE EVENT (No adverse event) in a 43-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7248B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 17-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 17-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up).    Concomitant medications details were not reported by the reporter.  Patient ID was reported.  It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.  Reportedly, in this report the patient was not Eligible. Breakdown of doses were reported as 51 doses from batch number AS7140C and 60 doses from Batch number AS7148B.  Treatment details were not reported by the reporter.   This case was linked (E2B Linked Report).; Sender's Comments:  Master case
High fever (103 degree), fast heart rate (120-130 heart beat per min). Mortrim administered but the fevel continues. Mortrim is able to lower the temp to 101 degrees. Heart rate continues to be fast. Have contacted doctor and waiting to go emergency visit tonight or going to see doctor tomorrow.
COVID Breakthrough. Patient presented to ED on 3/8/22 complaining of fatigue for 1 week and claims tested positive for COVID the day prior.
Crackling noted upon inhalation when lying supine beginning at the end of January.  Initial chest X-rays were normal. Continued respiratory symptoms which then began to cause pain with inhalation. Chest CT in June revealed mild pericardial effusion.
Pt began to feel lightheaded. He stated that his heart was beating fast and that his lips and hands were tingling. Pt was alert the entire time. EMS was called pt was evaluated pt decided to remain in the store and wait for his wife after EMS evaluated him and found no medical emergency.